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Abstract 
Background: Counselling is considered to be a promising approach to increasing physical activity (PA) in people 
with chronic obstructive pulmonary disease (COPD). The aim of the current study was to investigate whether a PA 
counselling program for people with COPD, when embedded in a comprehensive outpatient pulmonary rehabilita‑
tion (PR) program, increased their daily PA.
Methods: A two‑armed, single blind randomized controlled trial was conducted as a component of a 12‑week 
outpatient pulmonary rehabilitation program. The participants randomized into the intervention group received five 
counselling sessions, based on the principles of motivational interviewing (MI), with a physiotherapist. The partici‑
pants’ steps per day and other proxies of PA were measured using an accelerometer (SenseWear Pro®) at baseline, at 
the end of the PR program, and three months later. The group‑by‑time interaction effect was analyzed.
Results: Of the 43 participants,17 were allocated to the intervention group and 26 to the usual‑care control group 
(mean age 67.9 ± 7.9; 21 (49%) males; mean FEV1 predicted 47.1 ± 18.6). No difference between groups was found for 
any measure of PA at any point in time.
Conclusions: In this study, counselling, based on MI, when embedded in a comprehensive PR program for people 
with COPD, showed no short‑term or long‑term effects on PA behavior. To investigate this potentially effective coun‑
selling intervention and to analyze the best method, timing and tailoring of an intervention embedded in a compre‑
hensive outpatient PR program, further adequately powered research is needed.
Trial registration: Clinical Trials.gov NCT02455206 (05/21/2015), Swiss National Trails Portal SNCTP000001426 
(05/21/2015).
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Background
Physical activity (PA) promotion for patients with 
Chronic Obstructive Pulmonary Disease (COPD) is a 
research field of great importance. Both the American 
Thoracic Society (ATS) and the European Respiratory 
Society (ERS) have stressed that long-term self-manage-
ment and adherence to exercise at home should be the 
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primary goal of pulmonary rehabilitation programs (PR) 
[1]. Sound evidence has shown that physical inactivity 
in COPD patients is associated with an increased num-
ber of hospitalizations [2–4], and that it is the strongest 
predictor of all-cause mortality [3, 5]. Dyspnea, induced 
by physical exercise, may lead to a shift in a patient’s life-
style, resulting in a vicious cycle of decreased exercise 
tolerance. This, in turn, further reduces PA levels and 
increases the likelihood of social isolation and depres-
sion [6]. Conversely, the benefits of adequately dosed PA 
have been sufficiently proven [7–9]. PR, enhancement of 
exercise capacity, and promotion of an active life style are 
the cornerstones of non-pharmacological COPD man-
agement [10, 11]. However, poor adherence is common 
and changing behavior through enhancing motivation is 
a daily task for therapists [12–14]. Pitta & Burtin empha-
size the importance of having PA coaches as members of 
the PR team, for the purpose of, helping patients set and 
progress PA goals, reinforcing COPD self-care skills, sup-
porting efforts to monitor their activities and symptoms, 
assisting with problems, solving PA barriers, and trou-
bleshooting device or technology issues [15]. The use of 
Motivational Interviewing (MI) techniques for PA coun-
selling have been supported within the PR community 
[10, 16].
Miller and Rollnik ([17], p12) describe MI as a “col-
laborative conversation style for strengthening a person’s 
own motivation and commitment to change”. It focuses 
on the exploration and evocation of a person’s intrinsic 
motivation to change their perception towards a specific 
goal, e.g., daily PA. Hereby, MI emphasizes the ambiva-
lent attitude of a person to behavioral change, rather 
than seeing a person as unmotivated. Consequently, it 
is the therapist’s intention to detect a patient’s ambiva-
lence and to try to resolve it. This attitude is called “MI 
spirit” and is based on the four principles of: collabora-
tion, compassion, evocation and acceptance [17]. The 
process to change the behavior associated with PA can 
be divided into two phases; firstly, creation of the motiva-
tion to change, and secondly, the commitment to change. 
A non-judgmental and empathic communication style 
can help patients to make various behavior changes, e.g. 
quit smoking [18, 19], or to enhance treatment adherence 
[20].
In 2016, Lahham and colleagues showed that stud-
ies adding PA counselling, based on MI, to PR [21–24] 
resulted in an effect exceeding the established minimal 
important difference of 599 steps per day [25]. However, 
these pooled effects were demonstrated in the short-term 
at three months, but were not maintained in the longer-
term at six to 15 months [25].
Since 2016, several other studies have investigated the 
effect on PA behavior of adding MI-based PA counselling 
to PR, measured by steps per day. Benzo and colleagues 
(2018) did not find any difference in PA between groups 
when investigating the effect of MI-based health coach-
ing compared to usual care (PR) in people with COPD 
after hospitalization due to exacerbation [26]. A simi-
lar result was found by Arbilliga-Etxarri and colleagues 
(2018) investigating the effect of a 12-week program of 
MI-based PA promotion counselling, which was com-
bined with urban walking training, compared to usual 
care. However, a sub-analysis, including only those 
patients who were willing and adherent, showed a signifi-
cant effect on the number of steps per day [27].
While these studies indicate some positive effects of 
MI-counselling on PA in the short-term, no conclusive 
evidence is available on which strategy, using MI tech-
niques in the PR setting, could be effective in promoting 
long-term adherence to an active lifestyle. Both patients 
and health professionals have emphasized that the coach-
ing style and the relationship are important aspects of 
PA counselling [28]. Furthermore, the individual stage 
of change, based on the transtheoretical model of health 
behavior change [29], may be relevant to tailoring MI-
counselling. Data from well-designed interventional 
studies for people with COPD that look at the willingness 
to actually change habitual behavior are urgently needed 
[30].
The aim of the current study was to investigate whether 
a PA counselling program for people with COPD, when 
embedded in a comprehensive outpatient pulmonary 
rehabilitation (PR) program, increased their daily PA.
Methods
Design and ethics
The study design was a pragmatic, prospective two-arm 
single-blinded randomized controlled trial comparing a 
PA counselling group (IG) with a control group (CG) of 
usual-care. The regional ethics committee (EC,Canton 
Zurich) approved the study on  4th May 2015 (PB_2016-
01,523). Data collection was conducted in accordance 
with Good Clinical Practice protocols and the Decla-
ration of Helsinki principles. The COPD participants 
received written and oral information about the study. 
Written informed consent was obtained from all par-
ticipants prior to baseline measurement. The study was 
registered on the website of http:// www. Clinc alTra ils. gov 
with the identifier NCT02455206 (27/05/2015), as well 
as on the Swiss National Trails Portal SNCTP000001426 
(05/21/2015). The study protocol was also published [31].
Setting
This study was conducted at the Cantonal Hospital Win-
terthur (KSW), Institute of Physiotherapy and Division of 
Pneumology, Switzerland.
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Participants
Participants fulfilling the following inclusion criteria 
were eligible for the study: informed consent, as docu-
mented by signature; age 40–90  years and confirmed 
COPD (GOLD grades 2–4, according to GOLD-guide-
lines) [6]; German-speaking; and, planned participation 
in PR program. Exclusion criteria were applied as previ-
ously described [31]: summarized as, mental or physi-
cal disability, severe uncontrolled co-morbidities. Any 
adverse events occurring during the outpatient PR, such 
as injuries, increased respiratory symptoms, or cardiac 
events, were recorded and reported to the EC.
Recruitment and randomization
All individuals with confirmed COPD and referral to the 
pulmonary division of the KSW for PR were invited con-
secutively to participate in the study. No public adver-
tisement was made. Randomization was performed 
by an independent person, based on a list generated by 
computer software (R statistical software). Addition-
ally, stratification was used to ensure balanced exercise 
capacity (6-min walking test, 6MWD) in both groups at 
baseline, which could influence how sustainable someone 
can implement regular PA in everyday life. The randomi-
zation was accessible only to the responsible members 
of the research team. The assessors and statistician were 




A comprehensive PR was performed [32], according 
to the previously published study protocol [31], based 
on education and tailored individual intervention. Par-
ticipants attended a PR program at the outpatient clinic 
twice weekly (each session 1.5  h) and, additionally, per-
formed a supervised Nordic Walking training outdoors 
once a week (1.5-h session). Thus, a total of 36 physical 
training sessions were performed during the 12-week PR.
The sessions included dynamic strength training (per-
formed on conventional strength training equipment in a 
seated position) and cardio-pulmonary endurance training. 
For the strength training, patients started at 70% of their 
initial one-repetition maximum (1RM) and completed 
2 cycles of 6–12 repetitions of isotonic muscle contrac-
tions [33–35], with a resting period of 1–2  min between 
the series. If participants felt able to perform three sets of 
more than 15 repetitions without any difficulty, the train-
ing load was increased stepwise by 5% of the 1RM. Car-
dio-pulmonary endurance training was performed either 
on a cycle ergometer (sitting or recumbent) or a treadmill 
[33–35]. The initial training intensity was set at 70–80% of 
maximal exercise effort for 25 min. Increases in workload 
were based on symptom scores, which were assessed with 
a Borg scale. If patients were not able to perform 25 min of 
endurance training, interval endurance training was per-
formed [36].
Intervention group
Participants allocated to the IG received the usual 12-week 
PR program plus five face-to-face at weeks 1, 3, 6, 9 and 
12, 30-min counselling sessions, performed according to 
the principles of MI. The PA counselling was provided by 
two physiotherapists (MSc level), who were not involved in 
the usual PR program. They were trained prior to the study 
by an experienced MI-trainer and member of the MINT 
(Motivational Interviewing Network of Trainers).
Evaluation of counsellor communication skills
Counselling sessions were audiotaped. A fidelity check 
evaluated the general session content, as well as ran-
dom 20-min segments of the conversations, which were 
assessed by an external, independent MI-expert, accord-
ing to the Motivational Interviewing Treatment Integrity 
(MITI 4.2.1) [37, 38] criteria. Feedback was provided to the 
counsellors to strengthen their skills and consistency with 
the study intervention [39].
Measurements
Measurements, described in detail elsewhere [31], were 
performed at baseline (T0), after 12  weeks PR (T1), and 
after 24 weeks (follow-up, T2). Outcomes and Assessments 
are described in Table 1.
Analysis
The mean and standard deviation (SD) were presented for 
demographic and disease-specific data, median and associ-
ated range for continuous data, and frequencies (percent-
ages) for categorical variables.
The threshold for valid data from the accelerometer was 
set at four days, with a minimum wearing time of 22.5 h/
day [49]. The choice of days was decided as follows to cover 
a wide range of daily routine and associated activity levels 
[50]: (a) one day on the weekend, preferably Sunday; (b) the 
days during the week with the highest, the second highest, 
and the lowest time of activity.
For each continuous outcome, the following Linear 
Mixed Model was fitted to the data. The model for obser-
vation Yijk was
with µij as the mean for group i and time j, Uik as the ran-
dom effect of subject k in group i and εijk as measurement 
Yijk = µij + Uik + εijk , i = 1, 2;
j = 1, . . . , 3; k = 1, . . . , ni [51],
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error. Normal distributions were assumed for the random 
intercepts and the errors.
The parameters of interest were the between-group dif-
ferences in change between the time points 1–2, 1–3 and 
2–3, i.e., the group-by-time interactions. A global test for 
the group-by-time interaction effect was performed and 
95% confidence intervals for the interaction effects were 
computed by adjusting for multiple testing, where neces-
sary. Residual analysis was performed to check the model 
assumptions.
All analyses were performed using the R statistical soft-
ware R version 4.0.3 (2020-10-10) [51, 52].
Results
Patient recruitment and enrolment were started in June 
2015 and ended in March 2020 (ahead of schedule due 
to the Covid-19 pandemic). The patient flow is presented 
in the Consolidated Standards of Reporting Trial diagram 
(Fig. 1).
Of the 135 patients screened, 43 (32%) were included 
and allocated, either to the IG (n = 17) or to the CG 
(n = 26). One person allocated to CG dropped out before 
starting PR. At baseline, both groups were balanced in 
terms of gender, age, PA-related primary and secondary 
outcomes (Table 2). Patients had a median exercise ses-
sion attendance rate of 36 days (range 6–36; mean 33.3, 
SD 7.0).
Table  3 shows the outcomes for both groups at the 
three measurement time points. Neither the primary 
outcome of ‘steps per day’, nor the other proxies of PA 
(mean MET, TEE and PAL), showed any group-by-time 
differences (Table  4 and Fig.  2). Table  5, describing the 
PA stage of change for both groups, indicates that the 
majority of participants are in the stages of preparation, 
action or maintenance at all time points of measurement. 
The intervention fidelity of the counsellors was rated as 
sufficient.
Discussion
This study showed that counselling for people with 
COPD, based on MI principles, did not lead to an 
increase in daily PA, either during or after participation 
in a comprehensive outpatient PR. Despite some tenden-
cies, there was no robust group-by-time difference for a 
proxy of PA, or any other outcome.
This pragmatic study is deemed to be underpowered. 
The change in ‘steps per day’ corresponds to the minimal 
important difference (MID) [53], but is not statistically 
significant. The inhomogeneity of study participants is 
clear, thus limiting the validity of the findings. However, 
the individual PA behavior of the responders and non-
responders towards counselling can be identified. Some 
individuals benefited from counselling and responded 
well to the intervention. A qualitative analysis revealed 
four types of COPD patients, based on their perceived PA 
level, quality of motivation, and coping strategies. This 
might be useful to better understand the responders to 
counselling interventions [54].
These findings conform to the current literature. 
Although MI-counselling appears to be a promising 
intervention to promote behavioral change in peo-
ple with COPD [55], current results in the context of 
PA promotion are inconclusive. Two studies [23, 24], 
measured by steps per day and based on MI-techniques 
and pedometer feedback, showed positive short and 
long-term effects of counselling. However, another 
two studies [21, 22] showed no additional effect of 
MI-counselling on PA levels. A meta-analysis of these 
Table 1 Outcomes and assessments measured
PA, physical activity; PR, pulmonary rehabilitation; COPD, chronic obstructive pulmonary disease
Outcome Assessment
Primary PA: Mean number of steps per day Accelerometer (SenseWear Pro® armband; BodyMedia, Inc., Pittsburgh, PA, USA) [40]
Secondary Other proxies of PA
metabolic equivalent (MET),
total energy expenditure (TEE),
physical activity level (PAL)
Accelerometer (SenseWear Pro® armband; BodyMedia, Inc., Pittsburgh, PA, USA) [40]
Tertiary: Awareness of PA behavior International Physical Activity Questionnaire (IPAQ) [41, 42]
Individual motivation towards exercising Behavior Exercise Regulation Questionnaire (BREQ‑3) [43, 44]
The patient’s willingness to change their 
habitual behavior
Physical Activity Stage of Change Assessment Tool (PASC) [45]
Health‑related quality of life Chronic Respiratory Disease Questionnaire (CRQ) [46, 47]
Impact of COPD on health status COPD Assessment Test (CAT) [48]
PR adherence Number of sessions participation
Exercise capacity Six‑minute walking test (6MWT),
One‑minute Sit to stand (1STS), Pulmonary function
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four studies showed small to moderate effects at three 
months that tended towards statistical significance 
when PA counselling was added to PR (compared to 
PR only), but showed no long-term effects [25]. Addi-
tionally, Benzo and colleagues [26] concluded that tele-
phone-based MI, following PR, lead to reduced hospital 
readmissions, but that it had no effect on PA related 
outcomes.
In this study, a pedometer for activity tracking and 
feedback was not used. An alternative device without 
a feedback function was utilized. Raising awareness 
through feedback and self-monitoring are recognized 
techniques to support behavioral change [56]. Find-
ings from Altenburg [23] and Cruz [24] indicated that a 
pedometer support had short and long-term effects on 
the PA level. It could be a disadvantage not to offer direct 
feedback, such as with a pedometer, to every participant 
[57]. However, it is possible that the external feedback by 
pedometer could have raised patients’ motivation to be 
physically active and, consequently, decreased the effect 
of counselling between groups even more.
Donaire-Gonzales and colleagues [7] evaluated the 
interaction of quantity and intensity of PA and their 
effects on COPD hospitalization risk. For people with 
low average PA intensity, the risk of COPD hospitaliza-
tion was reduced by 20% for every additional 1′000 daily 
steps. Contrarily, and a little surprisingly, adding steps 
to an already high-intensity PA did not result in any risk 
reduction. This leads to the question of whether counsel-
ling should focus on the more active patients, i.e., those 
probably more willing to adopt an adequate PA behavior, 
or whether it is more important to specifically address 
inactive patients, who are probably less willing to change 
and less likely to adopt a sufficient PA behavior. Regard-
less of ethical considerations, a sophisticated counselling 
strategy performed by well-trained counsellors is needed. 
Although the best behavioral change strategies are still 
under debate, counselling has been recommended [58]. 
Fig. 1 Consort diagram describing the flow of patients. PR, pulmonary rehabilitation; IG, intervention group receiving physical activity counselling, 
CG, control group receiving usual care
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Important messages for COPD patients are: (a) Latest PA 
recommendations underpin the beneficial effects of PA 
for people with chronic diseases; since there is no lower 
threshold for benefits from PA, some benefits are inter-
mediate [59]; (b) Adults with COPD should do moder-
ate (150–300  min/week) and/or vigorous (75–150  min/
week) cardiovascular exercise, twice weekly strength 
exercise, flexibility and neuromotor exercises [59]; (c) The 
guidelines acknowledge that people with chronic con-
ditions should engage in PA according to their abilities 
and might need advice on the types and amounts of PA 
appropriate to their individual needs and abilities [59]; 
(d) Reduction of sedentary behavior is especially benefi-
cial for people with low PA.
Frequency of exercise training is a key factor to con-
sider, since it is assumed that frequent and structured 
training is more effective in increasing PA levels than 
irregular training. Studies involving exercise training of 
three times per week have demonstrated considerable PA 
improvement [60]. Furthermore, authors have concluded 
that longer-lasting PR programs achieve better improve-
ments in PA when compared to short-term PR programs 
[60]. In fact, studies in which the PR program lasted 
longer than 12  weeks achieved better PA levels than 
those in which the training was shorter (≤ 12  weeks). 
The longitudinal study of Pitta and colleagues stated that 
exercise training duration is fundamental. In this study, 
patients trained for 12 weeks and revealed a minor, non-
significant PA increase. The effect on PA only became 
significant for participants with supervised training over 
six months [61]. Since the participants in this current 
study participated in only 12 weeks of PR and trained 3 
times weekly, it might explain the lack of significant dif-
ference in PA between the groups.
Wempe and Wijkstra [62] confirmed that people usu-
ally needed a minimum of three months to change a 
habit: in fact, “one needs three months to train the mus-
cle, but six months to train the brain” [63]. To accurately 
investigate interventions and achieve a successful out-
come, frequent supervised exercise training should be 
provided over a longer period. It is generally acknowl-
edged that the chance of success of a behavioral change 
program increases when the intervention period exceeds 
six months. Prochaska [29] mentioned that, according to 
the Stages of Change model, individuals trying to change 
their behavior should initiate and remain in an “action” 
phase for six months prior to moving into the subsequent 
“maintenance” period. This might explain why the IG in 
our study only improved in the period T2.
The timing of counselling interventions might also 
be relevant to its effectiveness. In our study, partici-
pants received five 30-min counselling sessions at weeks 
1, 3, 6, 9, and 12. To facilitate the translation of regu-
lar exercise in the PR setting into that of daily life after 
PR, the counselling might have been more effective as a 
“bridging intervention” at the very end of, or following, 
PR. This would take into account the fact that COPD 
patients are generally less active directly following PR 
(need to recover), and that their level of PA may increase 
again later [64]. Whether a combination of presence 
and remote (digital) counselling could be an effective 
intervention needs to be evaluated, since evidence on 
Table 2 Characteristics of patients at baseline
n, number; SD, standard deviation; %, percentage; BMI, body mass index; 6MWD, six minutes walking distance; m, meter; FEV1, forced expiratory volume in 1 s; FVC, 
forced vital capacity; l, volume
Patient characteristics at baseline Control (n = 25) Intervention 
(n = 17)
Gender, m (%) 12 (48) 9 (53)
Age in years, mean (SD) 67 (9) 70 (7)
BMI, mean (SD) 25 (7) 27 (5)
Active smoker, yes (%) 8 (32) 8 (47)
Packyears, mean (SD) 46 (22) 53 (22)
N of cigarettes per day, mean (SD) 15 (12) 7 (3)
Years since stopped smoking, mean (SD) 9 (8) 12 (10)
N of exacerbations in last 12 months, mean (SD) 0.4 (0.7) 0.3 (0.4)
6MWD, m, mean (SD) 448 (72) 470 (90)
FVC, l, mean (SD) 2.6 (0.8) 2.7 (0.7)
FVC %, mean (SD) 77.1 (14) 85.5 (26)
FEV1, l, mean (SD) 1.1 (0.4) 1.3 (0.4)
FEV1, %, mean (SD) 45.6 (16) 52.5 (20)
FEV1_FVC, mean (SD) 53.6 (16) 56.7 (14)
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telerehabilitation in patients with COPD is growing fast 
[65–69]. However, research information on tele-counsel-
ling in a PR context is scarce [70]. Finally, whether coun-
selling is needed by all patients, or whether it is more 
effective in people willing to engage in the additional 
counselling service, needs to be investigated.
Even though adherence was good in this study, poor 
adherence in the general context of PR is common [71]. 
Lifestyle changes, which are part of the PR goals [32], 
require a great degree of effort from both clinicians and 
patients. Perceived beneficial effects and positive per-
sonal perceptions of MI encourage clinicians to learn 
and use MI in their daily working routines. Patients 
participating in this study appreciated the counselling 
intervention [54]. However, the poor recruitment rate 
of 32% suggests that patients did not initially find a 
study to evaluate a counselling intervention attractive. 
Possible reasons for this might be that the explanation 
of the counselling was not understood, or that patients 
did not see the need for self-induced behavioral change. 
Counselling, based on MI techniques, is already imple-
mented in many places. A number of stakeholders, such 
as the Swiss Lung Foundation [72] and the Working 
Group Pulmonary Rehabilitation of the three German-
speaking countries (CH, GER, AT) [73], promote the 
Table 3 Primary and secondary outcomes
IG, intervention group receiving physical activity counselling; CG, control group receiving usual care; SD, standard deviation; TEE, total energy expenditure; MET, 
metabolic equivalent of task; PAL, physical activity level; IPAQ, International Physical Activity Questionnaire; CRQ, Chronic Respiratory Disease Questionnaire; CAT, 
COPD Assessment Test; min, minutes; BREQ, Behavioral Regulation in Exercise Questionnaire
Primary and secondary outcomes Group n at T0 T0 n at T1 T1 n at T2 T2
Steps per day, mean (SD) IG 14 4987 (2751) 13 5026 (2859) 12 6054 (3560)
CG 18 5581(3413) 16 5651 (3582) 14 5180 (2803)
TEE per day, mean (SD) IG 14 2324 (746) 13 2196 (833) 12 2587 (1098)
CG 18 2440 (472) 16 2208 (416) 14 2163 (485)
MET per day, mean (SD) IG 14 1.3 (0.3) 13 1.3 (0.3) 12 1.3 (0.2)
CG 18 1.5 (0.5) 16 1.4 (0.2) 14 1.3 (0.3)
PAL per day, mean (SD) IG 14 1.6 (0.3) 13 1.5 (0.3) 12 1.5 (0.3)
CG 18 1.6 (0.3) 16 1.5 (0.1) 14 1.5 (0.2)
Time with low MET, minutes per day, mean (SD) IG 14 1321 (130) 13 1275 (183) 12 1277 (144)
CG 18 1299 (137) 16 1329 (75) 14 1298 (156)
Time with medium MET, minutes per day, mean (SD) IG 14 64 (83) 13 53 (44) 12 57 (61)
CG 18 78 (62) 16 57 (48) 14 61 (39)
Time with high MET, minutes per day, mean (SD) IG 14 2 (4) 13 1 (3) 12 3 (5)
CG 18 19 (33) 16 3 (6) 14 4 (10)
Time with very high MET, minutes per day, mean (SD) IG 14 0.2 (1.1) 13 0 (0) 12 1 (3)
CG 18 1.7 (3.7) 16 0.1 (0.3) 14 0.9 (3.2)
Average sitting time per day, minutes, mean (SD) IG 13 2155 (1276) 13 1536 (827) 12 1888 (792)
CG 18 2154 (960) 16 1918(911) 14 1709 (879)
IPAQ total METs of PA a week, mean (SD) IG 13 4246 (4715) 12 8819 (9632) 12 5891 (5363)
CG 18 2437 (2731) 13 6400 (5288) 14 5291 (5798)
IPAQ, mean minutes sitting time per day, mean (SD) IG 14 2155 (1276) 12 1536 (826) 12 1887 (791)
CG 18 2154 (969) 13 1918 (911) 14 1708 (878)
CRQ total, mean (SD) IG 17 17 (4) 15 21 (4) 14 21 (3)
CG 25 19 (5) 21 21 (5) 16 19 (4)
CAT, mean (SD) IG 13 21 (8) 9 17 (6) 0 NA
CG 21 15 (7) 19 12 (6) 0 NA
1‑Sit‑to‑stand, mean (SD) IG 17 24 (7) 15 30 (9) 15 26 (8)
CG 24 24 (9) 21 30 (11) 18 27 (9)
6‑min walking distance, m, mean (SD) IG 17 469 (90) 16 497 (89) 15 477 (93)
CG 25 447 (71) 23 469 (98) 18 469 (77)
BREQ3, score, mean (SD) IG 14 13 (7) 12 16 (4) 12 14 (6)
CG 16 7 (10) 18 16 (5) 14 13 (6)
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Table 4 Group‑time interactions for the periods T1‑T0, T2‑T0 and T2‑T1
MET, metabolic equivalent of task; 1STS, one-minute sit to stand; 6MWD, six-minute walking distance; SE, standard error; df, degrees of freedom; CI, confidence 
interval. Adjustment for multiple testing with sidak method
Outcome Time Period Estimate SE df Lower CI Upper CI t-value p-value
Mean steps T1–T0 323 773 49.1  − 1588 2235 0.42 0.96
T2‑T0 888 795 48.9  − 1078 2853 1.12 0.61
T2‑T1 564 803 48.3  − 1421 2550 0.70 0.83
Mean MET T1–T0 0.13 0.13 51.0  − 0.13 0.40 0.25 0.51
T2–T0 0.13 0.13 50.7  − 0.14 0.40 1.15 0.58
T2–T1  − 0.00  − 0.00 49.8  − 0.28 0.27  − 0.06 0.99
Mean time low MET T1–T0  − 77.5 66.8 55.2  − 242 87.1  − 1.16 0.58
T2–T0  − 45.7 66.8 55.2  − 212 123.8  − 0.66 0.88
T2–T1 31.8 70.2 54.5  − 141 204.8 0.45 0.95
Mean time moderate MET T1–T0 23.2 18.8 50.6  − 23.1 69.6 1.24 0.52
T2–T0 7.5 19.3 50.4  − 40.1 55.2 0.39 0.97
T2–T1  − 15.7 19.5 49.4  − 64.0 32.6  − 0.80 0.81
Mean time high MET T1–T0 15.6 7.6 54.8  − 3.2 34.4 2.04 0.13
T2–T0 15.7 7.9 55.0  − 3.7 35.1 2.00 0.14
T2–T1 0.1 8.0 54.1  − 19.7 19.9 0.02 1.00
1STS T1–T0 0.6 1.9 66.0  − 4.0 5.3 0.34 0.98
T2–T0 0.3 2.0 66.2  − 4.6 5.1 0.13 0.99
T2–T1  − 0.4 20.1 65.7  − 5.31 4.5  − 0.20 0.99
6MWD T1–T0 1.2 17.9 68.9  − 42.5 44.9 0.07 0.99
T2–T0  − 9.7 18.8 69.3  − 55.7 36.4  − 0.51 0.94
T2–T1  − 10.9 18.9 68.6  − 57.1 35.4  − 0.58 0.91
Fig. 2 A Mean steps per day, and B Mean MET at baseline (T0), 12 weeks (T1) and 24 weeks after PR (T2)
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learning and use of MI as a communication technique 
in the context of behavioral change.
This study has some limitations. The main problem was 
the extremely slow inclusion rate of eligible patients. This 
situation persisted despite continual improvement in the 
screening procedures. Finally, the lockdown due to the 
Covid-19 pandemic caused the premature discontinua-
tion of recruitment. This is the reason that the study is 
underpowered and that the findings should be inter-
preted with caution. During the long period of inclusion, 
some changes in clinical procedures were unavoidable 
due to routine quality improvements (e.g., exercise inter-
vention was changed from large groups to small groups 
for better tailoring of individual exercise training) and 
staff turnover (the team responsible for exercise interven-
tions changed). These quality improvement processes, 
and the individualization of PR may have caused a dilu-
tion of the counselling effects.
According to the original study protocol [31], the 
patients were to have been randomly allocated into 
blocks of four in each of two treatment arms. However, 
it became clear during the study that the randomization 
could not be implemented as planned. This limitation 
resulted in a different number of participants in the two 
arms of the study.
The accelerometer, SenseWear, is especially accurate 
and validated for this patient group [74, 75], but it not 
easily accessible to clinical practice. The device is more 
uncomfortable and less attractive than other more 
recently developed devices, such as a smart watch. Pro-
duction of the SenseWear device was ceased in 2015, 
resulting in no technical support being available dur-
ing the study. Some patients reported disturbing vibra-
tions or sounds from the SenseWear during resting 
periods. Furthermore, the data quality was sometimes 
insufficient and had to be excluded from the analyses 
(n = 25 data sets).
This study assessed PA stage of change in patients 
with COPD for the first time, to our knowledge. The 
resulting high number of missing questionnaires/non-
responses raises several questions. The PA stage of 
change assessment tool was translated into German 
using sound methodology; however, it was not validated 
in depth for patients with COPD. The low response rate 
could be due to a lack of understanding of the question-
naire, or it could be due to poor adherence. The general 
high proportion of missing patient reported outcomes 
in this study points towards the latter reason.
Although these limitations have had significant con-
sequences for the study results, lessons have been 
learned on how to conduct a study in this setting. The 
lack of statistically significant findings does not nec-
essarily mean that these effects do not exist. Future 
research with an adequate sample size, additional feed-
back strategy (e.g., pedometer), tailoring the MI inter-
vention to people willing to change, might present a 
different picture of PA counselling added to a compre-
hensive PR.
Conclusion
Counselling, based on MI principles, which was 
embedded in a comprehensive PR program for people 
with COPD, did not show any significant effect on PA 
behavior, either during or after PR. The mode, timing 
and tailoring of the intervention, as well as sample size, 
need to be further investigated to determine the use of 
this potentially effective, patient-centered intervention 
in an outpatient PR setting.
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